Cambia Powder, For Solution
Product Images NDC 13913-012

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cambia (NDC 13913-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Assertio Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cambia Figure 1)

Chemical structure of diclofenac potassium, showing its molecular arrangement with chlorinated phenyl rings and a potassium carboxylate group.*

FDA Label Image

Graph (Cambia Figure 2)

A line chart comparing the percent of subjects over time (hours) between Cambia and placebo groups. The x-axis represents hours from 0.00 to 2.25, and the y-axis shows the percent of subjects from 0 to 30%. Cambia group data is represented by a solid line, while placebo data is shown as a dotted line, illustrating a higher percentage of subjects over time in the Cambia group.*

FDA Label Image

Cambia 50 mg Individual Packet (Cambia Figure 3)

Label for Cambia 50 mg diclofenac potassium powder for oral solution. The label includes NDC 13913-012-01 and states Rx only. It shows directions on how to open the single dose packet. The product is labeled as manufactured by Depomed, Inc., with manufacturing by MiPharm S.p.A. in Milan, Italy, and distributed under license from APR Applied Pharma Research SA, Switzerland.*

FDA Label Image

Cambia 50 mg Box Of 9 Packets (Cambia Figure 4)

Packaging label for Cambia diclofenac potassium 50 mg oral solution powder by Assertio Therapeutics, Inc. The label shows directions for use, including dissolving the powder in water only. It also includes storage instructions, warnings to keep out of reach of children, and contains nine total packets. Manufacturing details and barcodes are visible.*

FDA Label Image

Cambia Figure 5

Box packaging label for Cambia 50 mg powder for oral solution, containing diclofenac potassium. The label shows the product name Cambia with colorful wave graphics and states it is manufactured by Depomed and labeled by Assertio Therapeutics, Inc. The package includes directions for use and a barcode. It is marked as a sample not for resale with NDC 13913-012.*

FDA Label Image

Cambia Figure 6

Packaging label for Cambia 50 mg powder for oral solution containing diclofenac potassium. The label displays the brand name Cambia prominently with dosage strength '50 mg Rx Only.' It includes the labeler name Assertio Therapeutics, Inc. (via Depomed branding), and instructions directing pharmacists to dispense the accompanying medication guide. The design features purple and blue color accents with dosage and safety precautions, including 'Keep out of reach of children' and 'No Coating. Lef/Exp.'*

FDA Label Image

Cambia Figure 7

Cambia 50 mg powder for oral solution containing diclofenac potassium. The label indicates it is a prescription drug (Rx Only) by Assertio Therapeutics, Inc., with instructions on how to open the single-dose packet. The package is marked as a sample not for resale and includes the Depomed logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.